Evidence map›Paper›PMID 37273389›Full record

ArticleCureus2023

Characteristics of Late-Onset Spondyloarthritis: Data from the Moroccan Registry of Biological Therapies in Rheumatic Diseases.

Ahmed Mougui, Zineb Baba, Ihsane Hmamouchi, Redouane Abouqal, Ahmed Bezza, Fadoua Allali, Rachid Bahiri, Imad Ghozlani, Hasna Hassikou, Linda Ichchou and 5 more

Erratum issuedOpen access · diamondAbstract read
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 3 countries.

Ahmed MouguiRheumatology, EzarriHospital, Faculty of Medicine and Pharmacy of Marrakech, Mohammed VI University Hospital, Marrakech, MAR.
Zineb BabaRheumatology, Arrazi Hospital, Faculty of Medicine and Pharmacy of Marrakech, Mohammed VI University Hospital, Marrakech, MAR.
Ihsane HmamouchiLaboratory of Biostatistics, Clinical Research and Epidemiology, Mohammed V University, Rabat, MAR.
Redouane AbouqalLaboratory of Biostatistics, Clinical Research and Epidemiology., Mohammed V University, Rabat, MAR.
Ahmed BezzaRheumatology, Military Hospital Mohammed V, Ibn Sina University Hospital, Rabat, MAR.
Fadoua AllaliRheumatology B, El Ayachi Hospital, Ibn Sina University Hospital, University Mohamed V, Rabat, MAR.
Rachid BahiriRheumatology A, El Ayachi Hospital, Ibn Sina University Hospital, University Mohamed V, Rabat, MAR.
Imad GhozlaniRheumatology, Faculty of Medicine and Pharmacy, University Ibn Zohr, Agadir, MAR.
Hasna HassikouRheumatology, Military Hospital Moulay Ismail, Hassan II University Hospital, Meknes, MAR.
Linda IchchouRheumatology, Mohammed VI University Hospital, Mohammed I University, Oujda, MAR.
Saadia JananiRheumatology, Ibn Rochd University Hospital, Casablanca, Morocco, Casablanca, MAR.
Taoufik HarzyRheumatology, Hassan II University Hospital, Fes, MAR.
Redouane NiamaneRheumatology, Military Hospital Avicenne, Mohammed VI University Hospital, Marrakech, MAR.
Abdellah El MaghraouiRheumatology, Private Medical Office, Rabat, MAR.
Imane El BouchtiRheumatology, Ezarri Hospital, Faculty of Medicine and Pharmacy of Marrakech, Mohammed VI University Hospital, Marrakech, MAR.
Centre Hospitalier Universitaire Mohammed VI · MAMohammed V University · MAHôpital El Ayachi · MACentre Hospitalier Universitaire Hassan II · MACentre Hospitalier Universitaire Ibn Rochd · MAHôpital Militaire Avicenne · MAHôpital Militaire Moulay Ismail · MAMohamed I University · MAOffice National de l'Eau Potable · MAUniversité Ibn Zohr · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction The Assessment of SpondyloArthritis International Society (ASAS) criteria for axial and peripheral spondyloarthritis (SpA) allow for the classification of patients with an age of onset of disease of less than 45 years. However, SpA can start after this age. This study aimed to assess the characteristics of late-onset SpA (SpA>45 years) in the Moroccan registry of biological therapies in rheumatic diseases (RBSMR). Methods A cross-sectional study was conducted using the baseline data of the RBSMR. The protocol for the original RBSMR study was reviewed and approved by the Ethics Committee for Biomedical Research Mohammed V University - Rabat, Faculty of Medicine and Pharmacy of Rabat (approval number for the study was 958/09/19, and the date of approval was September 11, 2019), and all patients had given their written consent. Patients who met the 2009 ASAS criteria for SpA were included. They were divided into two groups: early-onset SpA (≤ 45 years) and late-onset SpA (>45 years). Clinical, biological, radiological, and therapy data of the two groups were compared. Statistical analysis was performed using SPSS v25 software (IBM Corp. Armonk, NY). Parameters with a p-value ≤0.05 were considered significant. Results Our population consisted of 194 patients. Thirty-one patients (16%) had late-onset SpA. Comparison between patients with early-onset (≤45 years) and late-onset SpA (>45 years) revealed that late-onset SpA had a higher tender joint count (p=0.01), a higher swollen joint count (p=0.02), depression (p=0.00), fibromyalgia (p=0.001), hypercholesterolemia (p=0.01), and a lower frequency of coxitis (p=0.008). Logistic regression analysis confirmed that late-onset SpA was associated with a higher tender joint count (OR=0.93, CI 95%: 0.88-0.98), a higher swollen joint count (OR=0.92, CI 95%: 0.85-0.99), depression ( OR=0.19, CI 95%:0.04-0.38), fibromyalgia (OR=1.75, CI 95%: 1.74-17.85), and a lower frequency of coxitis ( OR=0.29, CI 95%: 0.11-0.75). Conclusion As life expectancy increases, late-onset SpA will become increasingly common. It is therefore imperative to determine its characteristics. In the RBSMR study, late-onset SpA was associated with a high number of tender and swollen joints, depression, fibromyalgia, and a lower frequency of coxitis.

Indexed as

characteristicsdiagnosislate onsetregistryspondyloarthritis

Identifiers

PMID37273389
PMCPMC10234029
OpenAlexW4376891868

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.